Nottingham Respiratory Research Unit
04 May 2016
NRRU COPD research VEVAS, runner up in CRN awards
The Nottingham Respiratory Research Unit (NRRU), is dedicated to delivering high quality, patient-centred research, in order to advance knowledge and improve health outcomes for people with respiratory conditions such as Asthma, COPD, ILD and Lung Infection.
By Integrating research with clinical care, we have established ourselves as one of the leading respiratory research units in the UK, with a proven track record of successful study recruitment and positive patient experience.
"Patient and public involvement is integral to and a vital part in us conducting high quality clinical research leading to improved treatments and care of patients with respiratory diseases"
You can have a say about our research, by joining our Patient and Public Involvement (PPI) Advisory Panel.
Your experiences and opinions are important to us. You do not need to have any research experience, just an interest in being involved.
Asthma clinical trial participant Anne says, it's "The best thing I've done"
This video is from an asthma patient who participated in one of our clinical research studies.
It is one of several in a series of patient video stories created by NUH Research and Innovation,
In addition, we are very grateful for funding from Nottingham Hospitals Charity. Our funders give us the support to enable us to perform high quality, world leading respiratory research. (See our facilities)
"From being greeted at the reception to the finish of the trials could not be improved upon. I felt completely at ease in all aspects from start to finish"
"What you are doing is excellent. Keep it up, you have a brilliant compliment of staff all pulling together to get results that will hopefully matter to our next generations"
“I found it very interesting and helpful in understanding the efforts being made to alleviate the symptoms of COPD.”
“It helped me to understand my asthma better. Thank you.”
18 August 2016
Annual Patient Survey Results. 98% of patients would be happy to participate in research again.